Insider Selling: CME Group Inc. (NASDAQ:CME) Director Sells 500 Shares of Stock

CME Group Inc. (NASDAQ:CME - Get Free Report) Director Charles P. Carey sold 500 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director now directly owns 4,900 shares in the company, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

CME Group Stock Down 0.5%

CME traded down $1.46 during mid-day trading on Friday, reaching $269.50. 1,576,352 shares of the stock were exchanged, compared to its average volume of 2,200,731. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a market capitalization of $97.12 billion, a PE ratio of 27.87, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a 50 day moving average price of $272.73 and a two-hundred day moving average price of $254.39. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.50 EPS. As a group, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.86%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is 50.30%.

Institutional Investors Weigh In On CME Group

A number of hedge funds have recently made changes to their positions in CME. Wayfinding Financial LLC purchased a new stake in CME Group during the first quarter valued at about $25,000. Cornerstone Planning Group LLC lifted its holdings in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. New Age Alpha Advisors LLC lifted its holdings in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Finally, Ransom Advisory Ltd purchased a new stake in CME Group during the first quarter valued at about $31,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CME has been the topic of several research analyst reports. Bank of America increased their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Barclays upped their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Piper Sandler upped their price target on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Finally, UBS Group upped their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of "Hold" and a consensus price target of $258.20.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.